EU/3/18/2031
Table of contents
About
On 27 June 2018, orphan designation (EU/3/18/2031) was granted by the European Commission to Air Liquide Santé (International), France, for argon for the treatment of perinatal asphyxia.
Key facts
Active substance |
Argon
|
Disease / condition |
Treatment of perinatal asphyxia
|
Date of first decision |
27/06/2018
|
Outcome |
Positive
|
EU designation number |
EU/3/18/2031
|
Review of designation
The Committee for Orphan Medicinal Products reviews the orphan designation of a product if it is approved for marketing authorisation.
Sponsor's contact details
Air Liquide Santé (International)
75 quai d’Orsay
75007 Paris
France
Tel. +33 1 49 69 82 00
E-mail: contact-healthcare-alsi@airliquide.com
75 quai d’Orsay
75007 Paris
France
Tel. +33 1 49 69 82 00
E-mail: contact-healthcare-alsi@airliquide.com
Patients' organisations
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.